just how dark does it have to get before our eyes stop working? Entirely dark, according to recent experiments. They suggest the human eye can detect the presence of a single photon, the smallest measurable unit of light, once it has been acclimated to the dark.

“If you imagine this, it is remarkable,” says Alipasha Vaziri, head of Rockefeller’s Laboratory of Neurotechnology and Biophysics, who conducted the research together with scientists at the Research Institute of Molecular Pathology in Austria. “A photon—the smallest physical entity with quantum properties of which light consists—is interacting with a biological system consisting of billions of cells. And the response that the photon generates survives all the way to the level of our awareness.”

Data

A 60-watt incandescent lightbulb emits roughly 8.2 quintillion photons per second.

Earlier studies had established that the human eye meets its limit at flashes of five to seven photons, but these experiments may have lacked the technology needed to produce such tiny, precise bursts of light. “It is not trivial to design states of light that contain exactly one or any other number of photons,” Vaziri says. His team was able to achieve this by implementing a combination of a psychophysics procedure and a quantum light source that can generate single-photon light states. The results, which combined data from more than 30,000 trials, were published in Nature Communications.

magnify a cell a few ten thousand times, and a pilled-sweater pattern starts to emerge. Some of the cell’s internal structures are covered with tiny, dense bumps called ribosomes, molecular machines made of RNA and protein whose job is to manufacture other proteins.

To keep growing, a cell has to produce thousands of new ribosomes every minute. If it fails to do so, it won’t be able to divide. So if you want to get rid of certain cells, their ribosome assembly line might make a useful target.

In studying how yeast cells piece their ribosomes together, a team led by Tarun Kapoor has discovered a compound they believe might be developed into an effective antifungal medication. The researchers report in Cell that the drug, called Rbin-1, throws a wrench into the ribosome assembly process, halting the proliferation of yeast cells. “Not only does this compound efficiently inhibit the growth of yeast cells, it does so through a unique mechanism,” says Kapoor, who is Pels Family Professor.

That’s welcome news, since the repertoire of antifungal treatments is presently slim. And yeast infections—even generally benign ones like thrush—can be devastating if they spread throughout the body, especially in people with weakened immune systems.

A growing cell can generate 2,000 or more ribosomes every minute, each assembled by a workforce of some 200 proteins.

“No antifungals with new mechanisms of action have been approved by the FDA for the past several years,” says Kapoor, “and no antifungal currently on the market interferes with ribosomal assembly.”

In young mice, wounds heal quickly. New skin cells, shown in green, have arrived to seal a wound within five days of the injury.

the older we get, the slower our bodies mend.

Scientists have been intrigued by this aspect of aging at least since World War I, when French surgeons serving at the front line documented that similar-size wounds healed a lot faster in 20-year-old soldiers than in 40-year-olds. Still today, biologists are trying to pinpoint exactly what changes in the body to slow down the wound-healing process.

One explanation is that skin cells called keratinocytes lose their ability to communicate with nearby immune cells.

Whenever the skin is breached, the body’s first response is to form a scab, and keratinocytes then travel in under the scab to seal the wound from below. Rockefeller researchers examined this process in 2- and 24-month-old mice—roughly equivalent to 20- and 70-year-old humans—and found that keratinocytes in the older mice took longer to arrive in the scab-coated cut. They also observed that these keratinocytes failed to recruit specialized immune cells, which in younger animals gather around the wound and help.

It turns out that the signals the younger skin cells use to call upon immune cells can be manipulated to boost wound healing in older animals. In experiments done using skin tissue grown in a petri dish, the researchers were able to make aging keratinocytes behave more youthfully by rekindling specific signaling pathways within them.

Data

Number of Americans who suffer from chronic wounds, often as a complication of diabetes or other disease.

Elaine Fuchs, Rebecca C. Lancefield Professor, led the study, which was published in the November 2016 issue of Cell. She says the findings could lead to treatments that stimulate wound healing in elderly people.

“It may be possible to develop drugs to activate pathways that help aging skin cells communicate better with their immune cell neighbors,” she says, “and so boost the signals that normally decline with age.”

for ants, status is everything. In any one colony there are queens, workers, and drones—each with unique anatomy and behavior. They look different, act different, and have dramatically different life spans. Yet their genes are identical.

Daniel Kronauer, who keeps dozens of ant colonies in his Rockefeller lab, spends much of his time trying to understand precisely what accounts for this dramatic variation. And although others in the field thought they had a pretty good idea—they implicated a chemical process known as methylation for turning on and off individual genes—Kronauer decided to take another look.

His lab’s examination failed to confirm previous results, finding no differences in the amount of methylation between individual ants. The earlier studies, by looking only at averages in methylation levels between different insect types, missed the fact that there was also considerable variation between insects of the same type, Kronauer says.

“It turns out there is nothing there—the current evidence is inconclusive,” Kronauer says. “To understand what’s really going on we will need to conduct new experiments with higher resolution and more statistical power.”

to watch neural processes play out inside the brain, scientists typically have to compromise. They can either zoom in on a thin slice of tissue, producing detailed movies of the neurons firing within it—or view a big chunk of it as a murkier blur.

But Nicolas Renier likes to have the best of both worlds. A postdoc in Marc Tessier-
Lavigne’s Laboratory of Brain Development and Repair, he is mastering a new imaging technique that allows him to capture—in one crisp snapshot—all the neural activity within an entire mouse brain. He and his colleagues have applied it to study, among other things, the neural pathways that activate when mice are parenting their pups. And last year, Renier got the chance to show off the protocol to New York City Mayor Bill de Blasio, on campus for a biotech conference.

A critical step in the procedure is to make the tissue transparent by “clearing,” a chemical soak that takes one to two weeks. The result, as the mayor got to witness, is a see-through brain. Its inner regions can now be exposed by light-sheet microscopy, in which active neurons are captured in three dimensions, snapshot by snapshot (view a single snapshot in “Inside Alzheimer’s”). The method can be used to explore how the brain changes in disease, how it responds to a drug, or how it performs sophisticated computations like those involved in decision-making. “You can use it to map anything you want in the mouse brain,” Renier says.

if biologists have a soft spot for microbes, so do cheese makers. On a recent afternoon, high school students from Rockefeller’s Science Outreach lab took their microbiology know-how to a cheese cave—a smelly chamber in which the temperature, humidity, and atmosphere are carefully set to agree with lactose-fermenting bacteria used to ripen young cheese wheels.

Hosted by cheese monger Murray’s Cheese, the excursion was part of Learning at the Bench, a semester-long after-school program in which students learn to think like scientists and conduct real experiments.

After swabbing different regions of the cave, the students brought their samples back to Rockefeller to isolate strains and extract and genotype bacterial DNA—essential steps in deconstructing a microbial environment.

For more on Rockefeller’s Science Outreach program, look for @rockeduteam on Facebook or Messenger.

when the 2011 tornado “super outbreak” hit the central plains, it spawned 363 tornados that together caused more than 350 deaths and $11 billion in damage. It was the biggest tornado outbreak ever recorded—and it may be part of a larger trend.

According to Rockefeller’s Joel E. Cohen and Columbia University’s Michael Tippett, the average number of tornados per outbreak has increased by more than 40 percent since the mid-1950s, though the number of tornados per year has not changed. The two researchers have used mathematical tools to examine six decades worth of storm data collected by the National Oceanic and Atmospheric Administration.

It’s not known why serial tornados are getting increasingly common. The researchers reported in Science in December that they could not establish a direct relationship between the mounting outbreaks and a warming planet. This could mean that climate change has nothing to do with the increased clustering of tornados, or that scientists don’t understand the link.

Data

Although the U.S. has more tornados each year than any other country, the U.K. has the most per square mile.

Cohen, who is a mathematical population biologist rather than a climate scientist, and is Abby Rockefeller Mauzé Professor, notes that models from population biology often yield insights into other systems. In this case, he and Tippet applied Taylor’s law—a pattern previously verified in ecology and some human diseases—to study tornados. “We’ve used new statistical tools to put tornados under the microscope,” he says. “Analyzing thousands of tornados the way we would study living populations allowed us to discover new features of their outbreaks.”

although they may not know it, Rockefeller’s Mary Jeanne Kreek has been a hero to millions of heroin users. Her 1966 discovery showed that a compound developed as a painkiller could help opioid addicts transition to normal lives. It also launched a new framework for understanding addiction as a disease rather than a moral weakness.

Fifty years later, some things have changed, and some haven’t. Kreek’s original work on methadone—conducted with clinician Vincent Dole and psychiatrist Marie Nyswander—has given way to sophisticated studies that seek to understand the biological underpinnings of addictions to substances such as cocaine, alcohol, and cannabinoids.

Yet attitudes toward addicts, and political resistance to the use of methadone, remain stuck in the past. In the United States, abstinence-based therapies continue to dominate, partly for ideological reasons. Kreek, who is Patrick E. and Beatrice M. Haggerty Professor, has devoted effort throughout her career to championing the implementation of drug treatment programs at home and abroad.

“Addictions are not criminal behaviors, and they are not weaknesses,” she says. “They however do respond to treatments—and it’s unfortunate that we have tools available to treat opiate addiction, but we’re not using them.”

it’s the unwelcome visitor who never, ever leaves. Once inside the body, herpes simplex 1—the cause of painful and unsightly cold sores—can make its way into nerve cells, hide away within them, and possibly stick around for a lifetime. Until recently, no one knew how the virus manages to lie low for so long.

But with pictures captured at the level of individual atoms, a team led by Jue Chen, William E. Ford Professor, has figured out the virus’s secret: a sophisticated sabotage of the body’s inherent defenses.

Data

Samples prepared for cryo-election microscopy are chilled to -321 degrees Fahrenheit, eliminating the need for them to be chemically fixed or stained.

The immune system normally recognizes and destroys virus-infected cells based on molecular bar codes—tiny pieces of the virus displayed on the cells’ surfaces. Using cryo-electron microscopy, the researchers created molecular images revealing just how herpes interferes with this coding system. The virus, it turns out, clogs a transporter protein responsible for pumping these viral pieces into packaging stations inside cells, from where they are shuttled to the cell’s surface. By blocking this transporter, called TAP, the virus effectively hides its own bar code from the immune system.

“We haven’t been able to figure out how to inhibit these transporters,” Chen says, “but by studying how viruses do it, we might learn some good strategies.”